Vista Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.40",
    "chg": 0.18,
    "chgp": "2.49%",
    "dir": 1,
    "prev_price": "7.22",
    "mcapval": "45.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE427C01021",
    "curr_date": "Jun 16, 09:31 AM",
    "curr_time": "09:33 AM",
    "last_traded_at": "Jun 16, 09:31 AM IST",
    "bse_nse_vol": "56 ",
    "exc_status": "Active",
    "traded_date": "Jun 16, 2026",
    "traded_date_str": "2026 06 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4035921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VistaPharmaceut_mojoScore_4035921.png",
        "date": "2026-06-04 10:10:20",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 04 June 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Are Vista Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vista-pharmaceuticals-ltd-latest-results-good-or-bad-4023722",
        "imagepath": "",
        "date": "2026-05-30 19:39:50",
        "description": "Vista Pharmaceuticals Ltd's latest financial results indicate a significant operational crisis, highlighted by a complete absence of revenue in the fourth quarter of FY26, marking an unprecedented situation for the company. The net sales for this quarter were reported at ₹0.00 crores, representing a 100.00% decline compared to the previous year, which is indicative of a total cessation of commercial activities. This revenue collapse follows a trend of declining sales over the preceding quarters, where the company had already been struggling with profitability.\n\nThe net loss for Q4 FY26 was recorded at ₹5.86 crores, a substantial increase from the previous year, reflecting a worsening financial position. The operating profit before depreciation, interest, and tax (PBDIT) also deteriorated, resulting in a loss of ₹7.06 crores, which underscores the company's inability to manage its operational costs effective..."
      },
      {
        "title": "Vista Pharmaceuticals Q4 FY26: Operational Collapse Triggers Zero Revenue Quarter",
        "link": "https://www.marketsmojo.com/news/result-analysis/vista-pharmaceuticals-q4-fy26-operational-collapse-triggers-zero-revenue-quarter-4022955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VistaPharmaceut_quaterlyResult_4022955.png",
        "date": "2026-05-29 22:33:02",
        "description": "Vista Pharmaceuticals Ltd. reported a catastrophic fourth quarter for FY2026, with net sales collapsing to absolute zero from ₹3.23 crores in the same quarter last year, marking a complete operational shutdown. The micro-cap pharmaceutical company posted a net loss of ₹5.86 crores in Q4 FY26, representing a dramatic deterioration from the ₹1.50 crore loss recorded in Q4 FY25. The stock, however, surged 7.37% on May 29, 2026, to close at ₹8.59, reflecting speculative trading rather than fundamental improvement in a company with a market capitalisation of just ₹49.00 crores."
      },
      {
        "title": "When is the next results date for Vista Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vista-pharmaceuticals-ltd-4001621",
        "imagepath": "",
        "date": "2026-05-20 23:17:41",
        "description": "The next results date for Vista Pharmaceuticals Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4000837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VistaPharmaceut_mojoScore_4000837.png",
        "date": "2026-05-20 10:10:21",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 May 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3979598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VistaPharmaceut_mojoScore_3979598.png",
        "date": "2026-05-07 10:10:27",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3963141",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VistaPharmaceut_mojoScore_3963141.png",
        "date": "2026-04-26 10:10:13",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3947372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VistaPharmaceut_mojoScore_3947372.png",
        "date": "2026-04-15 10:10:17",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3932612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VistaPharmaceut_mojoScore_3932612.png",
        "date": "2026-04-03 10:10:14",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 03 April 2026, providing investors with the latest insights into its performance and prospects."
      }
    ],
    "total": 5721,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "29-May-2026",
      "details": "Board meeting outcome",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "SEBI Secretarial Compliance Report for the year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2026",
      "datetime": "19-May-2026",
      "details": "Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2026 2. Audit Report for the quarter and year ended 31.03.2026 3. Any other business with the permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-06-04 10:10:20

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 04 June 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Are Vista Pharmaceuticals Ltd latest results good or bad?

2026-05-30 19:39:50

Vista Pharmaceuticals Ltd's latest financial results indicate a significant operational crisis, highlighted by a complete absence of revenue in the fourth quarter of FY26, marking an unprecedented situation for the company. The net sales for this quarter were reported at ₹0.00 crores, representing a 100.00% decline compared to the previous year, which is indicative of a total cessation of commercial activities. This revenue collapse follows a trend of declining sales over the preceding quarters, where the company had already been struggling with profitability. The net loss for Q4 FY26 was recorded at ₹5.86 crores, a substantial increase from the previous year, reflecting a worsening financial position. The operating profit before depreciation, interest, and tax (PBDIT) also deteriorated, resulting in a loss of ₹7.06 crores, which underscores the company's inability to manage its operational costs effective...

Read full news article

Vista Pharmaceuticals Q4 FY26: Operational Collapse Triggers Zero Revenue Quarter

2026-05-29 22:33:02

Vista Pharmaceuticals Ltd. reported a catastrophic fourth quarter for FY2026, with net sales collapsing to absolute zero from ₹3.23 crores in the same quarter last year, marking a complete operational shutdown. The micro-cap pharmaceutical company posted a net loss of ₹5.86 crores in Q4 FY26, representing a dramatic deterioration from the ₹1.50 crore loss recorded in Q4 FY25. The stock, however, surged 7.37% on May 29, 2026, to close at ₹8.59, reflecting speculative trading rather than fundamental improvement in a company with a market capitalisation of just ₹49.00 crores.

Read full news article

When is the next results date for Vista Pharmaceuticals Ltd?

2026-05-20 23:17:41

The next results date for Vista Pharmaceuticals Ltd is scheduled for 29 May 2026....

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-05-20 10:10:21

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 May 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-05-07 10:10:27

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-04-26 10:10:13

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-04-15 10:10:17

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2026-04-03 10:10:14

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 03 April 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

View All News